References
- Searls DB. Data integration: challenges for drug discovery. Nat Rev Drug Discov. 2005 Jan 01;4:45. online.
- Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update. Nucleic Acids Res. 2013;41(D1):D991–D95.
- The UniProt Consortium. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2017;45(D1):D158–D69.
- Sterling T, Irwin JJ. ZINC 15 – ligand discovery for everyone. J Chem Inf Model. 2015;55(11):2324–2337.
- European bioinformatics institute. [cited 2019]. Available from: https://www.ebi.ac.uk/
- National center for biotechnology information (NCBI). Bethesda (MD): National Library of Medicine (US), National Center for Biotechnology Information. 1988 [cited 2019]. Available from: https://www.ncbi.nlm.nih.gov/
- Nguyen D-T, Mathias S, Bologa C, et al. Pharos: collating protein information to shed light on the druggable genome. Nucleic Acids Res. 2017;45(Databaseissue):D995–D1002.
- Koscielny G, An P, Carvalho-Silva D, et al. Open targets: a platform for therapeutic target identification and validation. Nucleic Acids Res. 2017;45(Databaseissue):D985–D94.
- Khaladkar M, Koscielny G, Hasan S, et al. Uncovering novel repositioning opportunities using the open targets platform. Drug Discov Today. 2017;22(12):1800–1807.
- Reisdorf WC, Chhugani N, Sanseau P, et al. Harnessing public domain data to discover and validate therapeutic targets. Expert Opin Drug Discov. 2017;12(7):687–693.
- Williams AJ, Harland L, Groth P, et al. Open PHACTS: semantic interoperability for drug discovery. Drug Discov Today. 2012 Nov;17(21–22):1188–1198.
- Ajami A, Buvailo A. 36 web resources for target hunting in drug discovery; 2017 [ cited 2019]. Available from: https://www.biopharmatrend.com/post/45-27-web-resources-for-target-hunting-in-drug-discovery/
- LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436.
- Goodfellow I, Bengio Y, Courville A. Deep learning; 2016 [cited 2019]. Available from: http://www.deeplearningbook.org/
- Trapnell C. Defining cell types and states with single-cell genomics. Genome Res. 2015;25(10):1491–1498.
- Chen H, Engkvist O, Wang Y, et al. The rise of deep learning in drug discovery. Drug Discov Today. 2018;23(6):1241–1250.
- Rubingh CM, Bijlsma S, Derks EP, et al. Assessing the performance of statistical validation tools for megavariate metabolomics data. Metabolomics. 2006;2(2):53–61.
- Christin C, Hoefsloot HC, Smilde AK, et al. A critical assessment of feature selection methods for biomarker discovery in clinical proteomics. Mol Cell Proteomics. 2013 Jan;12(1):263–276.
- Gligorijevic V, Barot M, Bonneau R. deepNF: deep network fusion for protein function prediction. Bioinformatics. 2018 Jun 1.
- Rohart F, Gautier B, Singh A, et al. mixOmics: an R package for ‘omics feature selection and multiple data integration. PLoS Comput Biol. 2017 Nov;13(11):e1005752.
- Eser U, Churchman LS. FIDDLE: an integrative deep learning framework for functional genomic data inference. bioRxiv. 2016.
- Ngiam J, Khosla A, Kim M, et al. Multimodal deep learning. Proceedings of the 28 th International Conference on Machine Learning; Bellevue, Washington, USA. 2011.
- Chen J, Xie Y, Wang K, et al. Generative invertible networks (GIN): pathophysiology-interpretable feature mapping and virtual patient generation. CoRR. 2018. abs/1808.04495.